Comment contacter le centre
Centre de soins de santé
Avec environ 14.100 XNUMX salariés, l'UKE est le troisième employeur de la Ville libre et hanséatique de Hambourg.
La recherche à l'UKE
La recherche est une condition préalable importante au progrès du diagnostic et de la thérapie. Les recherches de l'UKE mettent l'accent sur les neurosciences, la recherche cardio-vasculaire, la recherche sur les soins, l'oncologie, ainsi que les infections et les inflammations. D’autres domaines potentiels de l’UKE sont la recherche en imagerie moléculaire et en biologie du squelette.
Contactez-Nous
Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
équipe
Pr Martin Spitzer
Allemagne
Dr Johannes Birtel
Allemagne
Essais cliniques
A Phase 3, Randomized, International Multicenter Trial of DAY101 Monotherapy Versus Standard of Care Chemotherapy in Patients with Pediatric Low-Grade Glioma Harboring an Activating RAF Alteration Requiring First-Line Systemic Therapy
A Phase 3 Multicenter, Randomized, Double Masked, Sham- Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
A Phase 2b Pivotal Study to Evaluate the Efficacy and Safety of Izokibep in Subjects With Non-infectious, Intermediate-, Posterior- or Pan-uveitis
European Disease Registry on Retinopathy of Prematurity (ROP)
Early Reperfusion Therapy With Intravenous Alteplase for Recovery of VISION in Acute Central Retinal Artery Occlusion
A Phase III, Multicentre, International Study With a Parallel, Randomised, Double-blind, Placebo-controlled, 2 Arm Design to Assess the Efficacy and Safety of Selumetinib in Adult Participants With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas (KOMET)
An Open-label, Active-Controlled, Safety, and Efficacy Study of Oral Baricitinib in Patients From 2 Years to Less Than 18 Years Old With Active Juvenile Idiopathic Arthritis-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis